These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14761074)

  • 1. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men.
    Düsing R
    Blood Press Suppl; 2003 Dec; 2():29-34. PubMed ID: 14761074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women.
    Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Jan; 17(1):77-81. PubMed ID: 14700518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual activity in hypertensive men.
    Della Chiesa A; Pfiffner D; Meier B; Hess OM
    J Hum Hypertens; 2003 Aug; 17(8):515-21. PubMed ID: 12874608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical and social implications of sexual dysfunction and safety of antihypertensive therapy in hypertensive patients].
    Vertkin AL; Vilkovyskiĭ FA; Skotnikov AS; Zviagintseva EI; Skotnikova EV
    Kardiologiia; 2011; 51(10):46-52. PubMed ID: 22117681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension therapy. Does AT-1 blocker help love life?].
    MMW Fortschr Med; 2003 Feb; 145(9):57. PubMed ID: 12666537
    [No Abstract]   [Full Text] [Related]  

  • 6. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study.
    Fogari R; Zoppi A; Poletti L; Marasi G; Mugellini A; Corradi L
    Am J Hypertens; 2001 Jan; 14(1):27-31. PubMed ID: 11206674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
    J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
    Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ
    J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome.
    Baumhäkel M; Schlimmer N; Böhm M;
    Int J Impot Res; 2008; 20(5):493-500. PubMed ID: 18596705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
    Mann J; Julius S
    Blood Press; 1998 May; 7(3):176-83. PubMed ID: 9758088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
    Shigenaga A; Tamura K; Dejima T; Ozawa M; Wakui H; Masuda S; Azuma K; Tsurumi-Ikeya Y; Mitsuhashi H; Okano Y; Kokuho T; Sugano T; Ishigami T; Toya Y; Uchino K; Tokita Y; Umemura S
    Nephron Clin Pract; 2009; 112(1):c31-40. PubMed ID: 19342867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction.
    Donatucci C; Taylor T; Thibonnier M; Bangerter K; Gittelman M; Casey R;
    J Sex Med; 2004 Sep; 1(2):185-92. PubMed ID: 16422973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
    Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
    Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.